Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription

Tatva Chintan Pharma IPO subscribed 4.51 times on first day of subscription The portion meant for qualified institutional buyers (QIBs) was subscribed 50 per cent, while the non-institutional investors' category received 1.14 times subscription and those for retail individual investors (RIIs) 8.24 times, according to an update on NSE. https://ift.tt/eA8V8J